国内要怎么购买地拉罗司？

Dispersible tablets are a new type of oral iron-removing agent. It is the first oral iron-removing agent that can be used routinely in the United States. It is approved for use in 2-year-old patients with chronic iron overload caused by blood transfusion. Clinical research is currently underway in China. Deferasirox is used to treat chronic iron overload caused by frequent blood transfusions in beta-thalassemia patients older than 6 years old, and has the advantage of good treatment compliance. Today we will take a look at how to buy deferasirox in China?

Deferasirox has been launched in China. According to the latest data sampling, the domestic specifications of Deferasirox are 125mg/tablet-28 tablets/bottle (box), and the price is 2330$; Deferasirox It requires the patient to take it continuously, which in the long run will be a heavy financial burden for the patient; then turn to India: Deferasirox from Novartis in Switzerland, the specification is 400mg*30 tablets/box, and the price is about $700. The specification of Deferasirox in India is 500*30 tablets/box, and the price is about $500. It is extremely cost-effective and reduces the financial pressure on patients to a great extent!

  If Chinese patients want to buy Indian Deferasirox, they can prepare relevant strategies for going abroad to see a doctor, go to a regular hospital in India for consultation in person, and then get the medicine. If the patient has no relevant experience in going abroad and is worried about the language barrier and cannot communicate with Indian doctors, he or she can also seek help from regular domestic medical institutions. The staff of the medical institution will solve the patient's related problems.

Deferasirox is a ligand with three protrusions. Although the affinity of deferasirox dispersible tablets to zinc and copper is very low, the concentrations of these trace metals in the serum still decreased to varying degrees after administration. The tolerability and safety of deferasirox are relatively good among similar drugs. Therefore, patients can also take it for a long time, but it is best to consult a doctor first and use it under the guidance of a doctor to avoid adverse reactions.

Deferasirox may cause a rash. Generally, the rash will disappear automatically without the need to adjust the dose or stop the medication. If the condition is severe or persistent, the medication should be stopped. 2. The patient’s vision or hearing may be affected. 3. It should be taken 30 minutes before meals. Avoid combining deferasirox with strong inducers of UDP-glucuronosyltransferase (UGT) (such as rifampicin, phenytoin, sedatives and hypnotics, protease inhibitors) and cholestyramine. Nor should it be administered with aluminum-containing antacids.

The above is the content of purchasing channels, I hope it can help you!